Recently, the U.S. Food and Drug Administration’s (FDA’s) Office of Combination Products (OCP) published the final guidance “Principles of Premarket Pathways for Combination Products,” which provides ...
Combination products, i.e., those containing any combination of a drug, device, or biological, constitute a growing category of innovative medical products. Examples include a drug with an implantable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback